Sometimes, seeing isn’t believing. Across the country, Americans are losing weight faster than ever thanks to blockbuster obesity drugs like Wegovy and Zepbound, with roughly one in eight US adults now turning to GLP-1s to slim down. But for some users, the dramatic physical changes come with an unexpected psychological twist. Users of GLP-1 drugs … Read more
They’re slimming their frames in Jesus’ name. For the A-list likes of Oprah Winfrey and Andy Cohen, Ozempic and other anti-obesity shots have hit the spot. For controversial “Almond Moms” like supermodel-turned-reality TV star Yolanda Hadid, eating just a few nuts a day is the way. But unlike the VIPs and their thin-by-any-means schemes, Kayla Bundy, … Read more
Costco shoppers aren’t sweating high prices. They’re sweating in home saunas. Inflation, international warfare and sociopolitical in-fighting across the US, apparently, cannot hold a candle to self-indulgence as sales on personal care products such as perfume, jewelry, saunas, makeup and massage chairs recently skyrocketed amid the economic crisis, per Costco Chief Financial Officer, Gary Millerchip. … Read more
GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and deadliest cancers for women. Blockbuster weight loss drugs like Ozempic and Wegovy have been linked to numerous benefits beyond weight loss, such as cutting the risk of obesity-related cancers in half. And new … Read more
Ozempic and its ilk are inescapable. While those on the weight loss drug often face more judgment and stigma, it’s undeniable that the medications have had an effect on many people’s health. As GLP-1 medications continue to evolve and become more popular, they’re having both a major moment and impact in the health landscape. Weight … Read more
A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a sleep apnea drug called AD109. After various clinical trials, they are preparing to file for FDA approval. “A pill for sleep apnea has always been … Read more
Popular glucagon-like peptide-1 (GLP-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference. Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers. The findings will be presented at the 2026 ASCO … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
Having children can feel like a massive gamble — there’s no guaranteed path to success. Much of conception is out of our control, and in many ways, it comes down to the numbers. The more high-quality eggs a woman produces, the better her chances of achieving a healthy pregnancy. Age is the most significant factor … Read more
Balding might make you blue — but this news won’t. A recent study suggests that a controversial liquid popular in biohacking and wellness circles could support scalp health and hair growth. Researchers say the substance may even hold promise for GLP-1 users with thinning crowns, a frustrating side effect that’s become increasingly common as the … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. For the last few years, it seems like Ozempic has been the main drug calling the shots in weight loss. But now, some health experts — and hordes of social … Read more
Brooke Hinderhan thought she had turned a corner with her health. After metformin failed to control her diabetes, doctors prescribed Ozempic. For a time, the popular GLP-1 drug worked, bringing her blood sugar under control. Even the side effects were manageable — until she developed severe fatigue, followed by diarrhea and stomach cramps that left … Read more
In the Ozempic era, not all pounds lost are met with praise. New research suggests that people may face more judgment for slimming down with the help of a GLP-1 drug than if they hadn’t lost weight at all. “We expected there might be some stigma around using a GLP-1,” Erin Standen, assistant professor of … Read more
America didn’t lose all its malls to the internet. It traded them in for Botox. Walk into any strip center worth its rent in 2025 and you’ll find the same thing: a med spa where the shoe store was and an IV drip lounge where the electronics store used to be. Now there’s data to … Read more
Medical innovation has really give people a shot at better heart health. About 805,000 people in the US have heart attacks every year, with one occurring every 40 seconds — and an alarming increase in those under 45. But new blockbuster medications that have taken the health world by storm could offer protection from adverse … Read more
Eau, eau, eau, Eau-zempic! You’ve heard of “Ozempic butt,” “Ozempic fingers,” “Ozempic mouth” and “Ozempic teeth” — now, there’s a new term to add to the GLP-1 lexicon: “Ozempic breath.” Bad breath is a common side effect of GLP-1 diabetes and weight loss drugs like Ozempic because they slow digestion, causing food to linger and … Read more
More than one in five Americans haven’t visited the optometrist in at least a year (22%) and another 15% “can’t remember” the last time they did so, according to new research. A survey of 2,000 U.S. adults looked at how respondents understand the importance of eye health and preventative care, finding that Gen Z is … Read more
Slimming down on a GLP-1 is one thing — keeping the pounds off after stopping the drug is another. But now, a groundbreaking new study suggests an experimental outpatient procedure may help prevent weight regain in patients no longer using the blockbuster diabetes and obesity meds. “As effective as GLP-1 medications are, many people stop … Read more
Your metabolism is no fool. Even if you initially lose weight on a certain diet or medication, to maintain those results, you have to constantly trick the metabolic system into letting you shed pounds. Otherwise, you might find yourself stuck at what obesity doctors call the “weight loss plateau.” This phenomenon is extremely common among … Read more
The exploding popularity of GLP-1 receptor agonists like Ozempic and Wegovy is often hailed as a public health triumph, but one potential side effect may be flying under the radar. The risk of divorce increases as weight drops, according to historical data from bariatric surgery patients. Some experts believe that the same pattern could occur as … Read more